APPY nice article Bob the risk/reward is heavily slanted in longs favor being a test & not a drug trial & has already had a trial with 97% success rate. Coupled with a 30 million dollar market cap & 20 million of that in cash. Throw in the Institutions discovering APPY seems like smart money to me. GLTA & make $$$$$$$$$$$$$$$$$$$$$$$$